CD36 and Human Fat Taste Perception
FATYP
CD36 Involvement on Fat Taste Perception and Fat Hedonic Value in Humans
1 other identifier
observational
97
1 country
1
Brief Summary
The purpose of this study is to determine the effect of common human variants in in taste related genes, such as CD36 gene, a putative fat taste receptor, affect fat taste perception.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Nov 2011
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2014
CompletedFirst Submitted
Initial submission to the registry
February 25, 2016
CompletedFirst Posted
Study publicly available on registry
March 4, 2016
CompletedMarch 4, 2016
February 1, 2016
1.4 years
February 25, 2016
February 29, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Scores in the general labeled magnitude scale for fat flavor intensity
One to 12 weeks following screening
Scores in the hedonic general labeled magnitude scale for fat flavor hedonic value
One to 12 weeks following screening
Secondary Outcomes (1)
Number of participants who are PROP taster as assessed by sip and spit testing procedure of water with increasing PROP concentrations.
One to 12 weeks following screening
Study Arms (4)
Lean AA
Subjects with a BMI\<=25 kg/m2 and carriers of a CD36 gene variation associated with low CD36 expression levels
Obese AA
Subjects with a BMI\>29.9 kg/m2 and carriers of a CD36 gene variation associated with low CD36 expression levels
Lean GG
Subjects with a BMI\<=25 kg/m2 and carriers of a CD36 gene variation associated with high CD36 expression levels
Obese GG
Subjects with a BMI\>29.9 kg/m2 and carriers of a CD36 gene variation associated with high CD36 expression levels
Interventions
Eligibility Criteria
Subjects will be men and women, 21 to 50 yrs of age of all races and ethnic groups. The two groups (i.e. groups with different CD36 genetic variants) will be matched as closely as possible in age, sex, body mass index and race distributions. Subject population will consist of lean subjects (BMI \>18-\<25 kg/m2) and subjects with obesity (BMI \>29.9 kg/m2).
You may qualify if:
- BMI \>18-\<25 kg/m2 or BMI\>29.9 kg/m2.
- to 50 years of age
You may not qualify if:
- Previous malabsorptive or restrictive gastrointestinal surgery
- Smoking
- Pregnancy or breastfeeding
- Diabetes
- Taking medication that might affect taste perception
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Washington University School of Medicine
St Louis, Missouri, 63110, United States
Biospecimen
Extracted genomic DNA
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Marta Y Pepino de Gruev, PhD
Washington University School of Medicine
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor of Medicine
Study Record Dates
First Submitted
February 25, 2016
First Posted
March 4, 2016
Study Start
November 1, 2011
Primary Completion
April 1, 2013
Study Completion
July 1, 2014
Last Updated
March 4, 2016
Record last verified: 2016-02
Data Sharing
- IPD Sharing
- Will not share